Rush Medical Center
Illinois Institute of Technology


Rush Site ImageMultimodal MRI biomarkers of small vessel disease for older persons with and without dementia

Summary

Small vessel disease (SVD) pathologies are very common in the brains of older persons and are related to decline in cognitive abilities, mild cognitive impairment, and dementia.  SVD pathologies include three common vessel diseases and an array of related tissue injuries.  SVD pathologies may cause dementia on their own (vascular dementia) but more commonly coexist with Alzheimer’s disease (AD) and other age-related pathologies where they lower the threshold for dementia.  Effective participant selection into trials, and prevention and treatment would greatly benefit from having in-vivo biomarkers of this pathology.  Current biomarkers are limited by lack of specificity for SVD (vs. AD) pathology and lack of pathologic validation.  We propose to overcome these obstacles by (1) further developing specific ex-vivo (post-mortem) MR imaging features of SVD pathologies after controlling for AD and other pathologies, in the brains of persons with and without dementia; (2) training a classifier using machine learning and multimodal MRI, and testing the classifier in persons without dementia, and whether it is related to cognitive status proximate to death; (3) translating the classifier into an in-vivo biomarker which can be investigated in relation to vascular risk factors and cognition, MCI, and dementia; and (4) validating the biomarker in a separate cohort (ADNI) and by autopsy confirmation of SVD pathologies in a large group of older persons followed longitudinally with MRI who agree to autopsy at death.  Finally we propose to (5) share data, expertise and biomarker strategies within the UH2/UH3 consortium and cross-validate selected biomarkers in older persons followed longitudinally with cognitive testing, blood draws and brain autopsy at the time of death.  We propose to leverage the resources of two longitudinal clinical-imaging-pathology cohorts, the Rush Memory and Aging Project (MAP) (R01AG017917) and Religious Orders Study (ROS) (P30AG010161), to accomplish these aims.

 

 

Investigators Information

PI: Julie Schneider, MD
Professor of Neurology
Neuropathology Associate Director
Rush Alzheimer's Disease Center
Rush University Medical Center

 

MPI: Konstantinos Arfanakis, PhD
Professor of Biomedical Engineering
Director MRI Program
Pritzker Institute
Illinois Institute of Technology

Copyright © 2017. All rights reserved.